Concepedia

Christopher I. Fincham

CI

9

Publications

198

Citations

9

H-Index

1992

Active since

Affiliations

Menarini Group (Italy)(Current)

Addenbrooke's Hospital

Christopher I. Fincham is an author at Menarini Group (Italy) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1992–2011

9

Publications

9

Amide bond replacements incorporated into CCK-B selective "dipeptoids"

Christopher I. Fincham, Michael Higginbottom, David R. Hill et al. · Journal of Medicinal Chemistry · 1992 · 61 citations · Full text

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist

R Cirillo, Mara Astolfi, Bruno Conte et al. · European Journal of Pharmacology · 1998 · 25 citations

, , +6

Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors

Cristina Rossi, Marina Porcelloni, Piero D’Andrea et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 23 citations · Full text

, , +7

Fragment-based drug design: combining philosophy with technology.

Sandra Bartoli, Christopher I. Fincham, Daniela Fattori · PubMed · 2007 · 22 citations

, , +15

The fragment-approach: An update

Sandra Bartoli, Christopher I. Fincham, Daniela Fattori · Drug Discovery Today Technologies · 2006 · 16 citations

, , +3

Rows per page

1–5 of 9